Linkage Analysis between Loci in the Renin-Angiotensin Axis and End-Stage Renal Disease in African Americans

Journal of the American Society of Nephrology

Volumn 7, Issue 12, 1996, Pages 2559-2564

  Yu, Hongrun ^a   Bowden, Donald W ^a   Spray, Beverly J ^a   Rich, Stephen S ^a   Freedman, Barry I ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b North Carolina Baptist Hospital   (United States)

Author keywords

African Americans; Angiotensin converting enzyme; Diabetic nephropathy; Hypertensive nephropathy; Renin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; KALLIKREIN; RENIN;

ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE LOCUS; GENETIC LINKAGE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NEGRO; NEPHROSCLEROSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN ANGIOTENSIN DISORDER;

EID: 0030394604     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. United States Renal Data System. USRDS 1994 Annual Data Report, Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994.
2. Ferguson R, Grim CE, Opgenorth TJ: A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 1988;41:1189-1196.
3. Freedman BI, Spray BJ, Tuttle AB, Buckalew Jr VM: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993;21:387-393.
4. Bergman S, Key BA, Kirk KA, Warnock DG, Rostand SG: Kidney disease in the first-degree relatives of African Americans with hypertensive end-stage renal disease. Am J Kidney Dis 1996;27:341-346.
5. Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end stage renal disease? Arch Intern Med 1991;151:1359-1364.
6. Byrne C, Nedelman J, Luke RG: Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis 1994;23:16-22.
7. Spray BJ, Atassi NG, Tuttle AB, Freedman BI: Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol 1995;5:1806-1810.
8. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 1996;12:44-51.
9. Jeunemaitre X, Soubrier F, Kotelevtsev Y, et al.: Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-180.
10. Caulfield M, Lavender P, Farrall M, et al.: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-1633.
11. Hata A, Namikaw C, Sasaki M, et al.: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-1287.
12. Rotimi C, Morrison L, Cooper R, et al.: Angiotensinogen gene in human hypertension: Lack of an association of the 235T allele among African Americans. Hypertension 1994;24:591-594.
13. Cambien F, Poirier O, Lecerf L, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond) 1992;359:641-644.
14. Tiret L, Kee F, Poirier O: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341: 991-992.
15. Ruiz J, Blanche H, Cohen N, et al.: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
16. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: U.K. prospective diabetes study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995;48: 1907-1911.
17. Lewis JL, Warnock DG: A polymorphism in the renin gene does not cosegregate with hypertension in a population of young F2 Dahl/Rapp rats. Presented at the 12th International Congress of Nephrology, Jerusalem, June 1993 (abstract book, pp 219).
18. Pravenec M, Kren V, Kunes J: Congregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 1991;17:242-246.
19. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
20. Davis E, Bonnardeaux A, Lathrop GM, Corvol P, Clauser E, Soubrier F: Angiotensin II (type-1) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet 1994;3:838.
21. Engelstein M, Hudson TJ, Lane JM: A PCR-based linkage map of human chromosome 1. Genomics 1993;15: 251-258.
22. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-75.
23. Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-121.
24. Richards RI, Holman K, Shen Y, et al.: Human glandular kallikrein genes: Genetic and physical mapping of the KLK1 locus using a highly polymorphic microsatellite PCR marker. Genomics 1991;11:77-82.
25. Weber JL, May PE: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-396.
26. S.A.G.E[1994]. Statistical Analysis for Genetic Epidemiology. Release 2.2. New Orleans, LA: Department of Biometry and Genetics, LSU Medical Center; 1994.
27. Risch N: Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990;46:229-241.
28. Risch N: Linkage strategies for genetically complex traits. III. The effect of marker polymorphisms on analysis of affected relative pairs. Am J Hum Genet 1990;46: 242-253.
29. Kruglyak L, Lander ES: Complete multipoint sib pair analysis of qualitative and quantitative traits. Am J Hum Genet 1995;57:439-454.
30. 2 and the problem of small samples. Mol Biol Evol 1989;6:539-545.
31. Waye JS, Eng B, Ni HY, Blajchman MA, Carmody G: Trinucleotide repeat polymorphism within the human antithrombin gene (AT3): Allele frequency data for three population groups. Mol Cell Probes 1994;8:149-154.
32. Qualheim RE, Rostand SG, Kirk KA, Rutsky DA, Luke RG: Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis 1991;18:336-343.
33. Schlessinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994;23:655-660.
34. Perneger TV, Whelton PK, Klag MJ, Rossiter KA: Diagnosis of hypertensive end stage renal disease: Effect of patient's race. Am J Epidemiol 1995;141:10-15.
35. Freedman BI, Turtle AB, Spray BJ: Familial predisposition to nephropathy in African Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-713.
36. Pettit DJ, Saad MF, Bennet PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990;33: 438-443.
37. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-1165.